The panel also included a senior scientist from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a senior medical officer from the National Heart, Lung, and Blood Institute (NHLBI), and a senior scientist from NHLBI who withdrew from authorship prior to publication.
Two members left the panel early in the process before the evidence review because of new job commitments that prevented them from continuing to serve.
Panel members disclosed any potential conflicts of interest including studies evaluated in this report and relationships with industry.
Those with conflicts were allowed to participate in discussions as long as they declared their relationships, but they recused themselves from voting on evidence statements and recommendations relevant to their relationships or conflicts.
Four panel members (24%) had relationships with industry or potential conflicts to disclose at the outset of the process.